FlightPath (Drug Discovery) Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $8.06M

  • Investors
  • 8

FlightPath (Drug Discovery) General Information

Description

Developer of antibiotic therapies designed to treat pathogen-driven diseases. The company's therapies kill co-infecting bacteria in Lyme disease to limit microbiome damage and treat multiple pathogenic bacteria in both the oral and gut microbiomes, enabling patients to get a new treatment to eradicate rare infectious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2600 Tenth Street
  • Suite 435
  • Berkeley, CA 94710
  • United States
+1 (415)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 2600 Tenth Street
  • Suite 435
  • Berkeley, CA 94710
  • United States
+1 (415)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

FlightPath (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC 23-Oct-2024 $8.06M Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 16-Dec-2021 Completed Pre-Clinical Trials
1. Accelerator/Incubator 08-Feb-2021 $100K $100K Completed Pre-Clinical Trials
To view FlightPath (Drug Discovery)’s complete valuation and funding history, request access »

FlightPath (Drug Discovery) Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A-4
Series A-3 125,512 $0.000010 6% $0.72 $0.72 1x $0.72 0.7%
Series A-2 2,720,246 $0.000010 6% $0.94 $0.94 1x $0.94 15.26%
To view FlightPath (Drug Discovery)’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

FlightPath (Drug Discovery) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibiotic therapies designed to treat pathogen-driven diseases. The company's therapies kill co-infecting
Drug Discovery
Berkeley, CA
4 As of 2026

San Carlos, CA
 

Cambridge, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

FlightPath (Drug Discovery) Competitors (2)

One of FlightPath (Drug Discovery)’s 2 competitors is Siolta Therapeutics, a Venture Capital-Backed company based in San Carlos, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Siolta Therapeutics Venture Capital-Backed San Carlos, CA
Seres Therapeutics Formerly VC-backed Cambridge, MA
You’re viewing 2 of 2 competitors. Get the full list »

FlightPath (Drug Discovery) Patents

FlightPath (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025090445-A1 Hygromycin a for treatment of diseases and infections Inactive 23-Oct-2023
WO-2025090508-A1 Hygromycin a for treatment of oral diseases and infections Inactive 23-Oct-2023
WO-2025090508-A9 Hygromycin a for treatment of oral diseases and infections Inactive 23-Oct-2023
AU-2022353095-A1 Hygromycin a for treatment of diseases and infections Inactive 24-Sep-2021
CA-3232874-A1 Hygromycin a for treatment of diseases and infections Pending 24-Sep-2021 A61K31/7048
To view FlightPath (Drug Discovery)’s complete patent history, request access »

FlightPath (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

FlightPath (Drug Discovery) Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ann Arbor SPARK Accelerator/Incubator Minority
Invest Detroit Ventures Corporate Venture Capital Minority
Michigan Rise Venture Capital Minority
Northern Michigan Angels Angel Group Minority
Red Cedar Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

FlightPath (Drug Discovery) FAQs

  • When was FlightPath (Drug Discovery) founded?

    FlightPath (Drug Discovery) was founded in 2019.

  • Where is FlightPath (Drug Discovery) headquartered?

    FlightPath (Drug Discovery) is headquartered in Berkeley, CA.

  • What is the size of FlightPath (Drug Discovery)?

    FlightPath (Drug Discovery) has 4 total employees.

  • What industry is FlightPath (Drug Discovery) in?

    FlightPath (Drug Discovery)’s primary industry is Drug Discovery.

  • Is FlightPath (Drug Discovery) a private or public company?

    FlightPath (Drug Discovery) is a Private company.

  • What is the current valuation of FlightPath (Drug Discovery)?

    The current valuation of FlightPath (Drug Discovery) is .

  • What is FlightPath (Drug Discovery)’s current revenue?

    The current revenue for FlightPath (Drug Discovery) is .

  • How much funding has FlightPath (Drug Discovery) raised over time?

    FlightPath (Drug Discovery) has raised $9.7M.

  • Who are FlightPath (Drug Discovery)’s investors?

    Ann Arbor SPARK, Invest Detroit Ventures, Michigan Rise, Northern Michigan Angels, and Red Cedar Ventures are 5 of 8 investors who have invested in FlightPath (Drug Discovery).

  • Who are FlightPath (Drug Discovery)’s competitors?

    Siolta Therapeutics and Seres Therapeutics are competitors of FlightPath (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process